As of November 6, 2026, Inventiva S.A. is a publicly traded company (Nasdaq: IVA). The largest holder reporting an active stake on Schedule 13D is Samsara BioCapital, L.P., at 7.4%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Sofinnova Partners SAS, a French corporation (8.6%), Andera Partners (6.7%) (Schedule 13D/A, November 19, 2025).
Is this your company?
About to sign with, pay or invest in Inventiva S.A.? See the free Snapshot first.
Free to see. No signup.
Is Inventiva S.A. a real, registered company?
- Inventiva S.A. files with the SEC under CIK 1756594 (its SEC filings).
- Its shares are listed under the ticker IVA on Nasdaq (also IVEVF) (SEC company record).
- Incorporated in I0; business address in Daix, I0, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under INVENTIVA S.A. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Andera Partners (filed 2026-10-27).
Who are Inventiva S.A.'s owners and officers?
Inventiva S.A.: business address in Daix, I0; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-27 | Andera Partners | 6.7% |
| Schedule 13G/A, 2026-05-15 | Deep Track Capital, LP | 3.76% |
| Schedule 13D/A, 2026-04-01 | New Enterprise Associates 17, L.P. | 4.9% |
| Schedule 13G/A, 2026-02-17 | Great Point Partners, LLC | 3.49% |
| Schedule 13G/A, 2026-02-17 | Andera Partners | 7.7% |
| Schedule 13G/A, 2026-02-17 | Sofinnova Partners Sas, A French Corporation | 8.6% |
| Schedule 13G/A, 2026-02-13 | Eventide Asset Management, LLC | 4.6% |
| Schedule 13G, 2026-01-30 | Deep Track Capital, LP | 6.07% |
| Schedule 13D/A, 2025-11-19 | Samsara Biocapital, L.P. | 7.4% |
| Schedule 13D/A, 2025-11-19 | Biotechnology Value Fund L P | 4.99% |
| Schedule 13G/A, 2025-11-14 | Perceptive Advisors LLC | 4.99% |
| Schedule 13G/A, 2025-11-14 | Great Point Partners, LLC | 6.06% |
Questions about who owns Inventiva S.A.
Who owns Inventiva S.A.?
On this page, 3 holders' latest ownership filings report 5% or more of Inventiva S.A.: Sofinnova Partners Sas, A French Corporation (8.6%, Schedule 13G/A, filed 2026-02-17), Samsara Biocapital, L.P. (7.4%, Schedule 13D/A, filed 2025-11-19) and Andera Partners (6.7%, Schedule 13G/A, filed 2026-10-27).
Who are the largest shareholders of Inventiva S.A.?
By the share each holder's latest filing reports, the largest holders of Inventiva S.A. on this page are Sofinnova Partners Sas, A French Corporation (8.6%), Samsara Biocapital, L.P. (7.4%) and Andera Partners (6.7%).
When did Sofinnova Partners Sas, A French Corporation buy into Inventiva S.A.?
The filings give report dates, not purchase dates. The earliest filing from Sofinnova Partners Sas, A French Corporation on this page is the Schedule 13G/A, filed 2026-02-17, reporting 8.6%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Inventiva S.A.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Inventiva S.A.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Inventiva S.A. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
How much has Inventiva S.A. raised?
No fundraising or offering filing from Inventiva S.A. is on file with us.
Keep reading
More on Inventiva S.A. and the records around it.
Inventiva S.A. elsewhere on the record
- 5%+ stake filings Oct 2026
Companies that share a holder
- Sofinnova Crossover I SLP also filed stake reports on 1 other company: Abivax S.A. (Jul 2026)
- Andera Partners also filed stake reports on 2 other companies: EVOMMUNE, INC. (Aug 2026), MINERALYS THERAPEUTICS, INC. (Aug 2025)
- New Enterprise Associates 17, L.P. also filed stake reports on 4 other companies: Monte Rosa Therapeutics, Inc. (Jul 2026), Korro Bio, Inc. (Mar 2026), SpyGlass Pharma, Inc. (Feb 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/inventiva-sa